Large-scale testing (Phase 3)UnknownNCT02409199What this trial is testingApatinib Versus Docetaxol Patients With Advanced Gastric CancerWho this might be right forGastric Carcinoma Shanghai Zhongshan Hospital 66
Not applicableLooking for participantsNCT06846996What this trial is testingReal-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in ChinaWho this might be right forHER2-positive Gastric CancerHER2-positive Gastroesophageal Junction Daiichi Sankyo 260
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Large-scale testing (Phase 3)UnknownNCT04714190What this trial is testingRC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-OverexpressionWho this might be right forGastric CancerHER2 Overexpressing Gastric Carcinoma RemeGen Co., Ltd. 351
Large-scale testing (Phase 3)Looking for participantsNCT06346197What this trial is testingCombination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric AdenocarcinomasWho this might be right forGastric CancerMSI-HMetastatic Cancer+1 more Centre Leon Berard 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116136What this trial is testingEvaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.Who this might be right forMSI-H/dMMR Gastroesophageal-junction CancerMSI-H/dMMR Gastric Cancer Servier Bio-Innovation LLC 38
Early research (Phase 1)Looking for participantsNCT07066657What this trial is testingMRG007 (ARR-217) in Patients With Advanced Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid TumorsColorectal CancerGastric Cancer+1 more ArriVent BioPharma, Inc. 405
Early research (Phase 1)Study completedNCT02711969What this trial is testingApatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard TreatmentWho this might be right forGastric Cancer Bukwang Pharmaceutical 6
Not applicableUnknownNCT04915807What this trial is testingReal-world Data (RWD) of Ramucirumab Plus PaclitaxelWho this might be right forGastric CancerGastroesophageal Junction Adenocarcinoma Hallym University Medical Center 222
Testing effectiveness (Phase 2)UnknownNCT04263870What this trial is testingConversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionWho this might be right forGastroesophageal Junction AdenocarcinomaStomach AdenocarcinomaLocally Advanced Unresectable Gastric Adenocarcinoma+1 more Sichuan University 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT07362186What this trial is testingLM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction AdenocarcinomaWho this might be right forLocally Advanced or Metastatic GC and GCJ Adenocarcinoma LaNova Medicines Limited 400
Testing effectiveness (Phase 2)Looking for participantsNCT07102901What this trial is testingSafety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction AdenocarcinomaWho this might be right forAdvanced Gastric CancerMetastatic Gastric CancerGastroesophageal Junction Adenocarcinoma Jiangsu HengRui Medicine Co., Ltd. 351
Testing effectiveness (Phase 2)Ended earlyNCT01774851What this trial is testingMM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and StomachWho this might be right forHER-2 Gene AmplificationEsophagus CancerGastroesophageal Junction Cancer+1 more Merrimack Pharmaceuticals 84
Testing effectiveness (Phase 2)UnknownNCT02504229What this trial is testingDC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of TreatmentWho this might be right forGastric Cancer Beijing Biohealthcare Biotechnology Co.,Ltd 80
Large-scale testing (Phase 3)Ended earlyNCT01641939What this trial is testingTrastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric CancerWho this might be right forGastric Cancer Hoffmann-La Roche 415
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Early research (Phase 1)Looking for participantsNCT06500052What this trial is testingBL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid TumorsWho this might be right forEsophageal CancerGastric CancerPancreatic Cancer+2 more Sichuan Baili Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT03924466What this trial is testingRepeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma PatientsWho this might be right forMetastatic Breast CarcinomaLocally Advanced Breast CancerCancer of Pancreas+11 more Universitair Ziekenhuis Brussel 55
Early research (Phase 1)Study completedNCT04319757What this trial is testingACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more Acepodia Biotech, Inc. 12
Early research (Phase 1)Looking for participantsNCT05365581What this trial is testingASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerWho this might be right forGastric AdenocarcinomaGastroesophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma Astellas Pharma Global Development, Inc. 398